Catch the WAVE – A discussion on using the WAVE disposable bioreactor for research and manufacturing operations

By on July 8, 2013
Ask the Expert

Our Next Session

Catch the WAVE – A discussion on using the WAVE disposable bioreactor for research and manufacturing operations.
Starts July 8, 2013.

An early pioneer in the area of disposable bioreactors, the WAVE Bioreactor was the first single-use bioreactor system when it was presented to the bioprocessing community in 1996. Since then, the range of products has expanded to include larger scale systems and advanced optical sensor and control technologies.  WAVE Bioreactor systems are today widely used in both research and manufacturing operations. The latest WAVE bioreactor, ReadyToProcess WAVE 25, combines the ease-of use that comes with the rocking technology as such, with intelligent control and advanced sensor technology. Don’t miss your chance to ask your questions about the use of disposable bioreactors.

This week’s session is hosted by Christian Kaisermayer, who currently holds the position of senior scientist at GE Healthcare. He is project manager for the development of cell culture media for vaccine applications and is based in Uppsala, Sweden. Christian also provides customer support and is involved in the scale up of virus propagation processes. He joined GE in 2007 and as a specialist for microcarrier applications supported several design-in projects and marketing activities. Christian then moved to a position in Fast Trak, a GE organization providing customer training and process development. In this function he developed several cell culture and bioreactor courses and trained customers in Europe, the US and Asia. Christian ran numerous application and process development projects related to single use bioreactors and microcarriers. Much of this work has been done in a research cooperation with a Vienna university institute that he is managing.

Christian has several years of experience in the development of fedbatch and perfusion processes for recombinant protein production and in the cultivation of adherent cells at laboratory and pilot scale. He received his PhD in Biotechnology from the University of Natural Resources and Applied Life Sciences in Vienna and also holds an engineering degree in Food Science and Biotechnology.

Please take advantage of the opportunity to ask our expert a question and participate in a lively discussion of hybridoma cell culture!

View Answers